Washington Regional Medical Center Selects Global Med's SafeTrace Tx(R) Transfusion Management System DENVER, Nov. 17 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), today announced the signing of an agreement with Washington Regional Medical Center in Fayetteville, Arkansas for SafeTrace Tx(R) Advanced Transfusion Management system. Terms of the agreement were not disclosed. "SafeTrace Tx was selected to manage our transfusion service because of its comprehensive safety features and its extensive management of patients and blood products," said Becky Magee, Vice President and CIO of Washington Regional Medical Center. Ms. Magee added, "SafeTrace Tx will help us deliver high quality services and blood products to our patients with greater efficiency." About Washington Regional Washington Regional, located in Fayetteville, Arkansas, is a locally owned and governed healthcare system whose services now reach 300,000 people in Washington, Benton, Madison and Carroll counties in Northwest Arkansas. Washington Regional Medical Center, established in 1950, is the flagship facility of Washington Regional. Information about Washington Regional is available on its website at http://www.wregional.com/ . About Global Med Technologies, Inc. Global Med Technologies, Inc. is an e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. blood centers and transfusion services. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Together, the SafeTrace Tx* Advanced Transfusion Management System and the SafeTrace(R) Donor Management System provide Vein- to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, call 800-WYNDGATE or visit http://www.globalmedtech.com/ , http://www.peoplemed.com/ and http://www.wyndgate.com/ . Press Inquiries: Investor Inquiries: Patti Larson Tom Marcinek Senior Director of Marketing Development President and COO 916-404-8492 916-404-8413 This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending DATASOURCE: Global Med Technologies, Inc. CONTACT: Press Inquiries, Patti Larson, Senior Director of Marketing Development, +1-916-404-8492, , or Investor Inquiries, Tom Marcinek, President and COO, +1-916-404-8413, , both for Global Med Technologies, Inc. Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.wregional.com/ Web site: http://www.globalmedtech.com/

Copyright